Purpose of ReviewWomen are living longer and spending nearly one third of their lives in the climact'/> Insomnia Pharmacotherapy: a Review of Current Treatment Options for Insomnia in Menopause
首页> 外文期刊>Current Forestry Reports >Insomnia Pharmacotherapy: a Review of Current Treatment Options for Insomnia in Menopause
【24h】

Insomnia Pharmacotherapy: a Review of Current Treatment Options for Insomnia in Menopause

机译:失眠药理疗:对更年期失眠的当前治疗方案综述

获取原文
获取原文并翻译 | 示例
           

摘要

AbstractPurpose of ReviewWomen are living longer and spending nearly one third of their lives in the climacteric period with the consequences of hypoestrogenism. Insomnia is the major clinical manifestation of this period. The aim of this chapter is to sum up current treatment options for menopausal insomnia and related symptoms. The paper summarizes some main treatment alternatives to treatment of insomnia in women, especially during the menopausal transition and postmenopause: What are the alternatives for treatment of insomnia in this population? What is the level of evidence of each of them?Recent FindingsPrevious studies have shown that the studies use very heterogeneous groups of women with different types of insomnia. This lack of standardized methods makes it difficult to identify the best therapeutic option for insomnia after menopause. However, this does not mean that it is impossible to define the best treatment intervention.SummaryThe findings from each therapy were categorized according to the level of evidence, based on the scientific knowledge. We highlight the importance of the patient being evaluated by a multidisciplinary team, and of taking a broad approach which considers both the pharmacological and biopsychosocial context to deliver the most effective treatment.]]>
机译:<![cdata [<标题>抽象 <标题>审查的目的 ara id =“par1”>女性生活更长时间,并花费近三分之一患有低生物发热后果的血液期。失眠是这一时期的主要临床表现。本章的目的是总结日期血管性失眠和相关症状的当前治疗方案。本文总结了一些主要治疗方法治疗女性失眠,特别是在日期血症过渡和后期期间:治疗该人群失眠的替代方案是什么?它们中每个每个证据级别是什么? <标题>最近的发现 ara id =“par2”>之前的研究表明研究使用具有不同类型的失眠的异构女性群体。这种缺乏标准化的方法使得难以在更年期后识别失眠的最佳治疗选择。然而,这并不意味着不可能定义最佳治疗干预。 <标题>摘要 ara id =“par3”>根据科学知识,根据证据水平分类每项治疗的结果。我们突出了多学科团队评估的患者的重要性,并采取广泛的方法考虑药理学和生物心细胞外观,以提供最有效的治疗方法。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号